79 related articles for article (PubMed ID: 8058046)
1. Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
Sachais BS; Krause JE
Mol Pharmacol; 1994 Jul; 46(1):122-8. PubMed ID: 8058046
[TBL] [Abstract][Full Text] [Related]
2. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
Jensen CJ; Gerard NP; Schwartz TW; Gether U
Mol Pharmacol; 1994 Feb; 45(2):294-9. PubMed ID: 7509441
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the species selectivity of the substance P antagonist CP-96,345.
Sachais BS; Snider RM; Lowe JA; Krause JE
J Biol Chem; 1993 Feb; 268(4):2319-23. PubMed ID: 7679096
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists.
Pradier L; Habert-Ortoli E; Emile L; Le Guern J; Loquet I; Bock MD; Clot J; Mercken L; Fardin V; Garret C
Mol Pharmacol; 1995 Feb; 47(2):314-21. PubMed ID: 7532784
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist.
MacDonald D; Silberman SC; Lowe JA; Drozda SE; Leeman SE; Boyd ND
Mol Pharmacol; 1996 May; 49(5):808-13. PubMed ID: 8622630
[TBL] [Abstract][Full Text] [Related]
7. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
Brodbeck RM; Sachais BS; Krause JE
Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
Gether U; Emonds-Alt X; Brelière JC; Fujii T; Hagiwara D; Pradier L; Garret C; Johansen TE; Schwartz TW
Mol Pharmacol; 1994 Mar; 45(3):500-8. PubMed ID: 8145735
[TBL] [Abstract][Full Text] [Related]
9. Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected].
Gether U; Nilsson L; Lowe JA; Schwartz TW
J Biol Chem; 1994 Sep; 269(39):23959-64. PubMed ID: 7929043
[TBL] [Abstract][Full Text] [Related]
10. Antagonists that demonstrate species differences in neurokinin-1 receptors.
Appell KC; Fragale BJ; Loscig J; Singh S; Tomczuk BE
Mol Pharmacol; 1992 Apr; 41(4):772-8. PubMed ID: 1373802
[TBL] [Abstract][Full Text] [Related]
11. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites.
Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ
Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580.
Fong TM; Yu H; Strader CD
J Biol Chem; 1992 Dec; 267(36):25668-71. PubMed ID: 1281470
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
[TBL] [Abstract][Full Text] [Related]
14. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor.
Fong TM; Yu H; Cascieri MA; Underwood D; Swain CJ; Strader CD
J Biol Chem; 1994 Jan; 269(4):2728-32. PubMed ID: 8300604
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors.
Engberg S; Ahlstedt I; Leffler A; Lindström E; Kristensson E; Svensson A; Påhlman I; Johansson A; Drmota T; von Mentzer B
Biochem Pharmacol; 2007 Jan; 73(2):259-69. PubMed ID: 17097619
[TBL] [Abstract][Full Text] [Related]
17. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
18. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
Aharony D; Little J; Thomas C; Powell S; Berry D; Graham A
Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285
[TBL] [Abstract][Full Text] [Related]
19. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
Cascieri MA; Huang RR; Fong TM; Cheung AH; Sadowski S; Ber E; Strader CD
Mol Pharmacol; 1992 Jun; 41(6):1096-9. PubMed ID: 1377326
[TBL] [Abstract][Full Text] [Related]
20. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor.
Elling CE; Nielsen SM; Schwartz TW
Nature; 1995 Mar; 374(6517):74-7. PubMed ID: 7532789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]